Z. Huang, C. Li, and C. Luo, “A Study on Financial Risk Early Warning in Pharmaceutical Companies: The Case of Ruikang Pharmaceutical”, HBEM, vol. 43, pp. 237–244, Dec. 2024, doi: 10.54097/8q2vwr78.